U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs
Source: SeekingAlpha
2025-04-01 05:40:00 ET
Summary
- The day of reckoning for tariffs is rapidly approaching, and we're anticipating substantial disruption for the pharmaceutical sector.
- For the US administration, tariffs on pharmaceuticals present conflicting policy goals.
- We see producers shifting some branded drug manufacturing from Europe to the US, while tariffs on Indian imports would drive up costs for American consumers.
New wave of tariffs incoming
Tomorrow, 2 April, the Trump administration is set to implement tariffs on parts of the world that were not covered by the initial round of tariff hikes. Some uncertainty still lingers around what exactly they'll cover, but it's likely that we'll see an increased tariff on goods imported from the EU....
Read the full article on Seeking Alpha
For further details see:
U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs
Virtus LifeSci Biotech Clinical Trials
NASDAQ: BBC
BBC Trading
-2.59% G/L:
$40.5014 Last:
6,854 Volume:
$41.88 Open:
